Uptake of CCR7 by KIR2DS4+ NK cells is induced upon recognition of certain HLA-C alleles

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Pesce, Silvia ^a   Carlomagno, Simona ^a   Moretta, Alessandro ^a   Sivori, Simona ^a   Marcenaro, Emanuela ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; HLA ANTIGEN CLASS 1; HLA C ANTIGEN; KIR2DS4 RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; RECEPTOR; UNCLASSIFIED DRUG; CCR7 PROTEIN, HUMAN; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR ALPHA; INTERLEUKIN 2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KIR2DS4 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C;

ALLELE; ARTICLE; CONTROLLED STUDY; CYTOFLUOROMETRY; CYTOLYSIS; CYTOTOXICITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PROTEIN EXPRESSION; PROTEIN INTERACTION; BIOSYNTHESIS; GENETICS; IMMUNOLOGY; METABOLISM; PROTEIN TRANSPORT; TRANSFORMED CELL LINE;

CELL LINE, TRANSFORMED; HLA-C ANTIGENS; HUMANS; INTERLEUKIN-18; INTERLEUKIN-18 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-2; KILLER CELLS, NATURAL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; PROTEIN TRANSPORT; RECEPTORS, CCR7; RECEPTORS, KIR;

EID: 84928974878     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/754373     Document Type: Article

References (55)

1. A. Cerwenka and L. L. Lanier, "Natural killer cells, viruses and cancer, " Nature Reviews Immunology, vol. 1, no. 1, pp. 41-49, 2001.
2. E. Vivier, D. H. Raulet, A. Moretta et al. , "Innate or adaptive immunity?The example of natural killer cells, " Science, vol. 331, no. 6013, pp. 44-49, 2011.
3. S. Sivori, S. Carlomagno, S. Pesce, A. Moretta, M. Vitale, and E. Marcenaro, "TLR/NCR/KIR: which one to use and when?" Frontiers in Immunology, vol. 5, article 105, 2014.
4. V. M. Braud, D. S. J. Allan, C. A. O'Callaghan et al. , "HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C, " Nature, vol. 391, pp. 795-799, 1998.
5. S. Sivori, M. Vitale, C. Bottino et al. , "CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies, " European Journal of Immunology, vol. 26, no. 10, pp. 2487-2492, 1996.
6. A. Moretta, C. Bottino, M. Vitale et al. , "Receptors for HLA class-I molecules in human natural killer cells, " Annual Review of Immunology, vol. 14, pp. 619-648, 1996.
7. L. L. Lanier, "NK cell receptors, " Annual Review of Immunology, vol. 16, pp. 359-393, 1998.
8. E. O. Long, "Regulation of immune responses through inhibitory receptors, " Annual Review of Immunology, vol. 17, pp. 875-904, 1999.
9. M. Uhrberg, N. M. Valiante, B. P. Shum et al. , "Human diversity in killer cell inhibitory receptor genes, " Immunity, vol. 7, no. 6, pp. 753-763, 1997.
10. P. Parham and A. Moffett, "Variable NK cell receptors and their MHC class i ligands in immunity, reproduction and human evolution, " Nature Reviews Immunology, vol. 13, no. 2, pp. 133-144, 2013.
11. A. Moretta, S. Sivori, M. Vitale et al. , "Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells, " Journal of Experimental Medicine, vol. 182, no. 3, pp. 875-884, 1995.
12. L. Olcese, A. Cambiaggi, G. Semenzato, C. Bottino, A. Moretta, and E. Vivier, "Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells, " The Journal of Immunology, vol. 158, no. 11, pp. 5083-5086, 1997.
13. J. H. Chewning, C. N. Gudme, K. C. Hsu, A. Selvakumar, and B. Dupont, "KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro, " The Journal of Immunology, vol. 179, no. 2, pp. 854-868, 2007.
14. C. A. Stewart, F. Laugier-Anfossi, F. Vély et al. , "Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 37, pp. 13224-13229, 2005.
15. T. Graef, A. K. Moesta, P. J. Norman et al. , "KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A?11 while diminishing avidity for HLA-C, " Journal of ExperimentalMedicine, vol. 206, no. 11, pp. 2557-2572, 2009.
16. G. Katz, G. Markel, S. Mizrahi, T. I. Arnon, andO. Mandelboim, "Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 41, " The Journal of Immunology, vol. 166, no. 12, pp. 7260-7267, 2001.
17. G. M. O'Connor, E. Yamada, A. Rampersaud, R. Thomas, M. Carrington, and D. W. McVicar, "Analysis of binding of KIR3DS1?014 to HLA suggests distinct evolutionary history of KIR3DS1, " The Journal of Immunology, vol. 187, no. 5, pp. 2162-2171, 2011.
18. P. Parham, "MHC class Imolecules and KIRS in human history, health and survival, " Nature Reviews Immunology, vol. 5, no. 3, pp. 201-214, 2005.
19. L. Moretta and A. Moretta, "Killer immunoglobulin-like receptors, " Current Opinion in Immunology, vol. 16, no. 5, pp. 626-633, 2004.
20. C. Bottino, S. Sivori, M. Vitale et al. , "A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation, " European Journal of Immunology, vol. 26, no. 8, pp. 1816-1824, 1996.
21. A. Thielens, E. Vivier, and F. Romagné, "NK cell MHC class I specific receptors (KIR): from biology to clinical intervention, " Current Opinion in Immunology, vol. 24, no. 2, pp. 239-245, 2012.
22. G. Alter, S. Rihn, K. Walter et al. , "HLA class I subtypedependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection, " Journal of Virology, vol. 83, no. 13, pp. 6798-6805, 2009.
23. S. A. Cassidy, K. S. Cheent, and S. I. Khakoo, "Effects of peptide on NK cell-mediated MHC I recognition, " Frontiers in Immunology, vol. 5, article 133, Article ID Article 133, 2014.
24. V. Béziat, L. L. Liu, J.-A. Malmberg et al. , "NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs, " Blood, vol. 121, no. 14, pp. 2678-2688, 2013.
25. M. Della Chiesa, M. Falco, A. Bertaina et al. , "Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/-umbilical cord blood, "The Journal of Immunology, vol. 192, no. 4, pp. 1471-1479, 2014.
26. M. Della Chiesa, E. Marcenaro, S. Sivori, S. Carlomagno, S. Pesce, andA. Moretta, "HumanNK cell response to pathogens, " Seminars in Immunology, vol. 26, no. 2, pp. 152-160, 2014.
27. M. P. Martin, X. Gao, J.-H. Lee et al. , "Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS, " Nature Genetics, vol. 31, no. 4, pp. 429-434, 2002.
28. K. Pelak, A. C. Need, J. Fellay et al. , "Copy number variation of KIR genes influences HIV-1 control, " PLoS Biology, vol. 9, no. 11, Article ID e1001208, 2011.
29. A. Rivero-Juarez, R. Gonzalez, A. Camacho et al. , "Natural killer KIR3DS1 is closely associated with HCV viral clearance and sustained virological response in HIV/HCV patients, " PLoS ONE, vol. 8, no. 4, Article ID e61992, 2013.
30. A. Olvera, S. Perez-Alvarez, C. Ganoza et al. , "Combined effect of HLA-C?04:01 and KIR2DS4 on increased HIV viral loads, " AIDS Research and Human Retroviruses, vol. 30, supplement 1, pp. A39-A40, 2014.
31. A. M. Merino, A. S. Dugast, C. M. Wilson et al. , "KIR2DS4 promotes HIV-1 pathogenesis: new evidence from analyses of immunogenetic data and natural killer cell function, " PLoS ONE, vol. 9, no. 6, Article ID e99353, 2014.
32. G. Katz, R. Gazit, T. I. Arnon et al. , "MHC class I-independent recognition ofNK-activating receptor KIR2DS4, " The Journal of Immunology, vol. 173, no. 3, pp. 1819-1825, 2004.
33. D. Pende, S. Marcenaro, M. Falco et al. , "Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidenticalHSCTfor pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity, " Blood, vol. 113, no. 13, pp. 3119-3129, 2009.
34. S. Sivori, S. Carlomagno, M. Falco, E. Romeo, L. Moretta, and A. Moretta, "Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT, " Blood, vol. 117, no. 16, pp. 4284-4292, 2011.
35. E. Marcenaro, S. Carlomagno, S. Pesce, M. della Chiesa, A. Moretta, and S. Sivori, "Role of alloreactive KIR2DS1+ NK cells in haploidentical hematopoietic stem cell transplantation, " Journal of Leukocyte Biology, vol. 90, no. 4, pp. 661-667, 2011.
36. E. Marcenaro, S. Pesce, S. Sivori, S. Carlomagno, L. Moretta, and A. Moretta, "KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DCs or T-cell blasts, " Blood, vol. 121, no. 17, pp. 3396-3401, 2013.
37. S. Cooley, D. J. Weisdorf, L. A. Guethlein et al. , "Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia, " The Journal of Immunology, vol. 192, no. 10, pp. 4592-4600, 2014.
38. E. Marcenaro, C. Cantoni, S. Pesce et al. , "Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction, " Blood, vol. 114, no. 19, pp. 4108-4116, 2009.
39. M. D. Chiesa, E. Romeo, M. Falco et al. , "Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function, " European Journal of Immunology, vol. 38, no. 8, pp. 2284-2289, 2008.
40. E. Ciccone, D. Pende, L. Nanni et al. , "General role of HLA class I molecules in the protection of target cells from lysis by natural killer cells: evidence that the free heavy chains of class I molecules are not sufficient to mediate the protective effect, " International Immunology, vol. 7, no. 3, pp. 393-400, 1995.
41. Y. Shimizu and R. DeMars, "Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLAA,-B,-C null human cell line, " Journal of Immunology, vol. 142, no. 9, pp. 3320-3328, 1989.
42. R. Biassoni, M. Falco, A. Cambiaggi et al. , "Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by 'group 2' or 'group 1' NK clones, " The Journal of Experimental Medicine, vol. 182, no. 2, pp. 605-609, 1995.
43. C. S. Falk, A. Steinle, and D. J. Schendel, "Expression of HLA-C molecules confers target cell resistance to some nonmajor histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells, " The Journal of Experimental Medicine, vol. 182, no. 4, pp. 1005-1018, 1995.
44. R. B. Mailliard, S. M. Alber, H. Shen et al. , "IL-18-induced CD83+CCR7+ NK helper cells, " The Journal of Experimental Medicine, vol. 202, no. 7, pp. 941-953, 2005.
45. C. M. Nielsen, M. J. White, M. R. Goodier, and E. M. Riley, "Functional significance of CD57 expression on humanNKcells and relevance to disease, " Frontiers in Immunology, vol. 4, article 422, 2013.
46. N. K. Björkström, P. Riese, F. Heuts et al. , "Expression patterns ofNKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education, " Blood, vol. 116, no. 19, pp. 3853-3864, 2010.
47. V. Beziat, D. Duffy, S. N. Quoc et al. , "CD56CD16+ NKcells: a functional intermediate stage of NK cell differentiation, " The Journal of Immunology, vol. 186, no. 12, pp. 6753-6761, 2011.
48. L. Moretta, "Dissecting CD56dim human NK cells, " Blood, vol. 116, no. 19, pp. 3689-3691, 2010.
49. M. J. White, C. M. Nielsen, R. H. C. Mcgregor, E. M. Riley, and M. R. Goodier, "Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigens, " Immunology, vol. 142, no. 1, pp. 140-150, 2014.
50. Y.-I. Son, R. M. Dallal, R. B. Mailliard, S. Egawa, Z. L. Jonak, and M. T. Lotze, "Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-production, and expansion of natural killer cells, " Cancer Research, vol. 61, no. 3, pp. 884-888, 2001.
51. T. A. Fehniger, M. H. Shah, M. J. Turner et al. , "Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response, " The Journal of Immunology, vol. 162, no. 8, pp. 4511-4520, 1999.
52. S. Agaugué, E. Marcenaro, B. Ferranti, L. Moretta, and A. Moretta, "Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells, " Blood, vol. 112, no. 5, pp. 1776-1783, 2008.
53. L. Moretta, F. Locatelli, D. Pende, E. Marcenaro, M. C. Mingari, and A. Moretta, "Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation, " Blood, vol. 117, no. 3, pp. 764-771, 2011.
54. L. Ruggeri, F. Aversa, M. F. Martelli, and A. Velardi, "Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self, " Immunological Reviews, vol. 214, no. 1, pp. 202-218, 2006.
55. L. Ruggeri, M. Capanni, E. Urbani et al. , "Effectiveness of donor natural killer cell aloreactivity in mismatched hematopoietic transplants, " Science, vol. 295, no. 5562, pp. 2097-2100, 2002.